España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Leerink Swann
After A Q4 Miss, LifePoint Health Downgraded By Leerink On Free Cash Flow Concerns
Leerink: Bluebird Bio's Catalysts Are Priced In
Plenty Of Opportunity In AbbVie, Even After Recent Run
Leerink: Bluebird Bio's Catalysts Are Priced In
Plenty Of Opportunity In AbbVie, Even After Recent Run
Teleflex On Accelerating Top-Line Growth Trajectory; Upgrading To Outperform
Globus Medical Stands On The Brink Of Inflection; Leerink Upgrades
Teleflex On Accelerating Top-Line Growth Trajectory; Upgrading To Outperform
Globus Medical Stands On The Brink Of Inflection; Leerink Upgrades
A Peek Into The Markets: U.S. Stock Futures Down; Jobless Claims In Focus
Leerink Swann Downgrades Kythera Biopharmaceuticals To Market Perform
Read More...
Leerink Swann Recent News
Leerink Swann Initiates Fitbit With Outperform
Leerink Swann Initiates Pacira Pharmaceuticals With Market Perform
Leerink Swann Initiates Fate Therapeutics With Outperform
Leerink Swann Initiates Horizon Pharma With Outperform
Leerink Swann Initiates Paratek Pharmaceuticals With Outperform
Leerink Swann Initiates Carbylan Therapeutics With Outperform
Leerink Swann Initiates Trillium Therapeutics At Outperform
Leerink Swann Initiates Team Health Holdings At Outperform
Leerink Swann Initiates ACADIA Pharmaceuticals At Outperform
Leerink Swann Downgrades Cellular Dynamics To Market Perform
Leerink Swann Initiates Invitae With Market Perform
Leerink Swann Initiates HealthEquity At Outperform
Leerink Swann Upgrades Medicines Company To Outperform
Leerink Swann Upgrades Boston Scientific To Outperform
Leerink Swann Downgrades Kindred Biosciences To Market Perform
Leerink Swann Initiates WebMD Health At Outperform
Leerink Swann Upgrades MedAssets To Outperform
Leerink Swann Initiates ITC Holdings With Outperform
Leerink Swann Upgrades Allergan To Outperform
Leerink Swann Reiterates on Aegerion Pharmaceuticals as Weakness is Overdone
UPDATE: Leerink Swann Initiates Coverage on WellPoint as There is Upside Amid the Winds of Change
UPDATE: Leerink Swann Initiates Coverage on UnitedHealth Group as There is Upside Amid the Winds of Change
UPDATE: Leerink Swann Initiates Coverage on WellCare Health Plans as Valuation Remains Compelling and Points to Multiple Expansion